• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4642682)   Today's Articles (36)   Subscriber (50541)
For: Cannon GW, Jackson CG, Samuelson CO, Ward JR, Williams HJ, Clegg DO. Chlorambucil therapy in rheumatoid arthritis: clinical experience in 28 patients and literature review. Semin Arthritis Rheum 1985;15:106-18. [PMID: 3865372 DOI: 10.1016/0049-0172(85)90028-9] [Citation(s) in RCA: 27] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Number Cited by Other Article(s)
1
Li MP, Yang N, Xu WR. Synthesis of a new water-soluble hexacarboxylated tribenzotriquinacene derivative and its competitive host-guest interaction for drug delivery. Beilstein J Org Chem 2022;18:539-548. [PMID: 35615534 PMCID: PMC9112186 DOI: 10.3762/bjoc.18.56] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Accepted: 05/02/2022] [Indexed: 11/23/2022]  Open
2
Systemic treatments for noninfectious vitreous inflammation. Mediators Inflamm 2013;2013:515312. [PMID: 24347829 PMCID: PMC3853923 DOI: 10.1155/2013/515312] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2013] [Accepted: 09/26/2013] [Indexed: 12/14/2022]  Open
3
Systemic treatment of vitreous inflammation. Mediators Inflamm 2012;2012:936721. [PMID: 23028205 PMCID: PMC3457724 DOI: 10.1155/2012/936721] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2012] [Accepted: 08/21/2012] [Indexed: 02/07/2023]  Open
4
Li WX, Yan X, Shi CR, Zhang AP. Chlorambucil for patients with primary biliary cirrhosis. Cochrane Database Syst Rev 2012;2012:CD008714. [PMID: 22972125 PMCID: PMC11374147 DOI: 10.1002/14651858.cd008714.pub2] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
5
Furst DE, Markalanda E, Clements PJ. Immunosuppressives (chlorambucil, cyclosporine, cyclophosphamide [Cytoxan], azathioprine [Imuran], mofetil, tacrolimus). Rheumatology (Oxford) 2011. [DOI: 10.1016/b978-0-323-06551-1.00055-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]  Open
6
Kim EC, Foster CS. Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use. Int Ophthalmol Clin 2006;46:141-64. [PMID: 16770160 DOI: 10.1097/00004397-200604620-00013] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
7
Okada AA. Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature. Ocul Immunol Inflamm 2006;13:335-51. [PMID: 16419419 DOI: 10.1080/09273940590951034] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
8
Morton SJ, Powell RJ. Management of systemic lupus erythematosus (SLE). Clin Exp Allergy 2001;31:686-93. [PMID: 11422127 DOI: 10.1046/j.1365-2222.2001.01123.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
9
Klippel JH. Indications for, and use of, cytotoxic agents in SLE. BAILLIERE'S CLINICAL RHEUMATOLOGY 1998;12:511-27. [PMID: 9890110 DOI: 10.1016/s0950-3579(98)80033-2] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
10
Cash JM, Wilder RL. REFRACTORY RHEUMATOID ARTHRITIS. Rheum Dis Clin North Am 1995. [DOI: 10.1016/s0889-857x(21)00367-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
11
Steinberg AD. Chlorambucil in the treatment of patients with immune-mediated rheumatic diseases. ARTHRITIS AND RHEUMATISM 1993;36:325-8. [PMID: 8452576 DOI: 10.1002/art.1780360306] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
12
Milligan A, Hutchinson PE. The use of chlorambucil in the treatment of bullous pemphigoid. J Am Acad Dermatol 1990;22:796-801. [PMID: 2189909 DOI: 10.1016/0190-9622(90)70111-t] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
13
Hart LE, Tugwell P. The use of disease modifying antirheumatic drugs in the management of rheumatoid arthritis. Postgrad Med J 1989;65:905-12. [PMID: 2694146 PMCID: PMC2429570 DOI: 10.1136/pgmj.65.770.905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
14
Cannon GW, Pincus SH, Emkey RD, Denes A, Cohen SA, Wolfe F, Saway PA, Jaffer AM, Weaver AL, Cogen L. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. ARTHRITIS AND RHEUMATISM 1989;32:964-73. [PMID: 2504171 DOI: 10.1002/anr.1780320805] [Citation(s) in RCA: 75] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
15
Willkens RF. New perspectives of secondary and tertiary therapy for rheumatoid arthritis. Drugs 1989;37:739-54. [PMID: 2663418 DOI: 10.2165/00003495-198937050-00007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA